Dr Richard Bergsrud, MD in Ruidoso Downs, NM - Orthopaedic Surgery

Dr Richard Bergsrud, MD is a Orthopaedic Surgery physician based in Ruidoso Downs, New Mexico. Dr Richard Bergsrud is licensed to practice in New Mexico (license number 94-11) and his current practice location is 205 Lacanada Drive, Ruidoso Downs, New Mexico. He can be reached at his office (for appointments etc.) via phone at (575) 208-0036.

NPI number for Dr Richard Bergsrud is 1447536677 and his current mailing address is Po Box 903, Mail Delivery Only At Pobox 903, Ruidoso Downs, New Mexico. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1447536677.

Contact Information

	Dr Richard Bergsrud, MD
	205 Lacanada Drive, Ruidoso Downs, NM 88346-0903
	(575) 208-0036
	(575) 208-0036

Physician's Profile

Full Name	Dr Richard Bergsrud
Gender	Male
Speciality	Orthopaedic Surgery
Location	205 Lacanada Drive, Ruidoso Downs, New Mexico
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1447536677
Provider Enumeration Date: 11/02/2011
Last Update Date: 11/02/2011

Medical Identifiers

Medical identifiers for Dr Richard Bergsrud such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447536677	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	94-11 (New Mexico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Richard Bergsrud is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Richard Bergsrud, MD Po Box 903, Mail Delivery Only At Pobox 903, Ruidoso Downs, NM 88346-0903 Ph: (575) 208-0036	Dr Richard Bergsrud, MD 205 Lacanada Drive, Ruidoso Downs, NM 88346-0903 Ph: (575) 208-0036

News Archive

New gold nanoparticle can transport powerful radioactive particles directly to tumors

We've all heard that "it's not wise to use a cannon to kill a mosquito." But what if you could focus the cannon's power to concentrate power into a tiny space? In a new study, University of Missouri researchers have demonstrated the ability to harness powerful radioactive particles and direct them toward small cancer tumors while doing negligible damage to healthy organs and tissues.

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

When treating prostate cancer with radiation therapy, side effects such as urinary problems and rectal pain and bleeding are a concern, as is impact on the patient's overall quality of life. So when new, more efficient treatment methods are developed, one important question is whether better treatment comes at the cost of increased side effects and decreased quality of life.

Certain leukemia oncogenes switch on genetic programs that govern self-renewal, a unique stem cell characteristic

Researchers have discovered that specific cancer-causing genes associated with leukemias can transform mature white blood cells into leukemic cells that have all the properties of stem cells.

French maternal and child health clinics threatened by poor economy

NPR's KQED on Wednesday examined how France's 60-year-old network of preventive health clinics for children and parents, which provides care free-of-charge, is being threatened by the nation's flailing economy.

Positive results from INSYS Therapeutics' phase III trial for Fentanyl SL Spray

INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.

Dr Richard Bergsrud, MD - Orthopaedic Surgery in Ruidoso Downs, NM